Form D Explorer
Mercury Bio, Inc. · CIK 1952927

Report a data issueCitable research briefCompare issuerPrivate research collection

Mercury Bio, Inc.

CIK 1952927 · Corporation · Inc. DELAWARE · SANTA FE, New Mexico · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filing history at a glance

The reported offering amount was $13,268 in the Nov 12, 2026 filing and $1,589,992 in the Nov 13, 2026 filing. The two records may concern different offerings. All 4 stored filings from Feb 21, 2025 to Nov 13, 2026 are original notices.

Filings
4
Original notices
4
Amendments
0
Activity
Feb 21, 2025
through Nov 13, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldNov 12, 2026 · DNov 13, 2026 · DLater minus earlier
Reported offering amount$13,268$1,589,992$1,576,724
Reported amount sold$13,268$1,589,992$1,576,724
Reported investor count132
Reported minimum investment$0$0$0

Earlier SEC source: 0001952927-26-000001 · Later SEC source: 0001952927-26-000002

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D · Nov 13, 2026

Reported offering amount
$1,589,992
Reported exemptions
Rule 506(b)
Reported amount sold
$1,589,992

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Form D filings (4)